Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Nusantara Sejahtera Raya Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Nusantara Sejahtera Raya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp93 (market cap 7.75T, 8.75M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B, 51K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 46.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (8.75M versus 51K). Which is the better fit depends on your goals.

CNMAOBAT
Market Cap
7.75T167.37B
Volume
8.75M51K
Lot
87.46K510
Turnover
815.8M12.55M
Average Price
93.28246.09
Value
815.8M12.55M
Indicative Equilibrium Price
94246
Indicative Equilibrium Volume
1.17K2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CNMA
View details
OBAT
View details

About Nusantara Sejahtera Raya Tbk.

PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.

Read more on CNMA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT